Recipharm
1995
FOUNDED
PUBLIC
STATUS
5K-10K
EMPLOYEES
RECI B
STOCK SYMBOL
28
INVESTMENTS
$15.18
SHARE PRICE
(As of Tuesday Closing)
Description
Recipharm AB is a global biotechnology company that develops pharmaceutical drugs and technologies. The company operates in two core areas that include development and technology, and manufacturing. Recipharm's largest business stream is its manufacturing operation, which focuses on delivering a large number of pharmaceuticals in a variety of dosage forms. This segment also provides packaging services for customers. The company's overall business model focuses on uniting licensed development and manufacturing companies.
Primary Industry
Pharmaceuticals
Stock Exchange
STO
Primary Office
- Box 603
- 101 32 Stockholm
- Sweden
+46 0000000000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Recipharm’s full profile, request a free trial.
Recipharm Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $11.29 - $16.48 | $1.03B | $15.24 | $0.33 | 182K | 67.8M |
Recipharm Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 1,344,914 | 1,207,578 | 1,191,070 | 1,097,531 |
| Revenue | 770,259 | 727,993 | 619,219 | 541,563 |
| EBITDA | 114,645 | 112,102 | 60,374 | 82,941 |
| Net Income | 22,918 | 18,320 | (19,949) | 22,022 |
| Total Assets | 1,384,822 | 1,414,645 | 1,432,941 | 1,079,378 |
| Total Debt | 488,702 | 496,932 | 511,527 | 284,349 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Recipharm Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Recipharm‘s full profile, request access.
Request full access to PitchBookRecipharm Competitors (24)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Corden Pharma | Venture Capital-Backed | Plankstadt, Germany | 0000 | 00000 00000 | ||
| 000 0000000 | Corporate Backed or Acquired | Riverview, MI | 00 | 000000&0 | ||
| 00000000 000000000 | Corporation | Gaithersburg, MD | 0000 | 000.00 | 000000000 | 000.00 |
| 00. 00000'0 000000 | Corporation | Hyderabad, India | 00000 | 00000 | 000000 - 000 | 00000 |
| 0000000000 0000000 | Private Equity-Backed | Sarasota, FL | 00 | 000000000000 |
Recipharm Investments & Acquisitions (28)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 0000000 | 18-Nov-2019 | 000000000000000000 | 00000 | Drug Delivery | |
| 0000000 000000 | 24-Apr-2019 | 00000 00000 00 | 00.000 | Drug Discovery | 0000-00000 0000 00.0 |
| 000000 (0000000000 | 01-Oct-2018 | 000000000000000000 | 000.00 | Pharmaceuticals | |
| 00000 000000000000 | 01-Jun-2018 | 000000000 00000000 | 000.00 | Pharmaceuticals | |
| Sanofi (manufacturing center) | 13-Jan-2018 | Corporate Asset Purchase | 000.00 | Buildings and Property |
Recipharm Exits (3)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 000000 | 02-Oct-2015 | 00000 00000 00 | 00.000 | Completed |
|
| 000000 | 29-Sep-2015 | 0000000000 | Completed |
|
|
| Cobra Biologics | 01-Jan-2009 | Merger/Acquisition | Completed |
Recipharm Subsidiaries (3)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| OnTarget Chemistry | Other Commercial Services | Uppsala, Sweden | 2008 |
| 00000 000000000000 | Pharmaceuticals | Karnal, India | 0000 |
| 00000 000000000 | Biotechnology | Keele, United Kingdom | 0000 |
Recipharm Executive Team (9)
3 Former Executives
You’re viewing 5 of 9 executives. Get the full list »